🔎 Trials Near Me

Hjem › B-celle lymfom › Wisconsin

B-celle lymfom kliniske forsøg i Wisconsin

10 studier for B-celle lymfom søger deltagere på steder i Wisconsin.

Byer i Wisconsin

Officiel studietekst (engelsk)

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

  • Children's Hospital of Wisconsin, Milwaukee
RekruttererObservationsstudie
Alder 0 til 38 · Alle køn · Opdateret 1. okt. 2026 · NCT06131801

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  • Research Site, Milwaukee
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06526793

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

  • University of Wisconsin, Madison
  • Medical College of Wisconsin, Milwaukee
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06634589

A Study of ARC-02 in B-cell NHL

  • Froedtert & Medical College of Wisconsin, Milwaukee
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Medical College of Wisconsin, Milwaukee
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT05826535

DALY II USA/ MB-CART2019.1 for DLBCL

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT04792489

Long-term Follow-up Study of Patients Receiving CAR-T Cells

  • Froedtert Hospital & Medical College of Wisconsin, Milwaukee
RekruttererObservationsstudie
Alder 18 til 80 · Alle køn · Opdateret 10. nov. 2025 · NCT03375619

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital of Wisconsin, Milwaukee
RekruttererFase 1
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.